跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
human factor VIII-Fc fusion protein
首页
药物
human factor VIII-Fc fusion protein
human factor VIII-Fc fusion protein
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
METHOD FOR EFFICIENTLY SEPARATING AND PURIFYING RECOMBINANT HUMAN COAGULATE FACTOR VIII FC FUSION PROTEIN
US 2023134182 A1
申请人: AMPSOURCE BIOPHARMA SHANGHAI INC
优先权: 2020
CN
EP
US
WO
4 件公开
Highly glycosylated human blood-clotting factor VIII fusion protein, and manufacturing method and application of same
US 11471513 B2
申请人: AMPSOURCE BIOPHARMA SHANGHAI INC
优先权: 2016
US
FUSION PROTEIN OF MUTATED SINGLE-CHAIN HUMAN COAGULATION FACTOR VIII, PREPARATION METHOD THEREFOR, AND USE THEREOF
EP 3858865 A9
申请人: AMPSOURCE BIOPHARMA SHANGHAI INC
优先权: 2018
EP
Method for purifying recombinant human coagulation factor VIII-Fc fusion protein
CN 117777310 A
申请人: CHENGDU RONGSHENG PHARMACEUTICALS CO LTD
优先权: 2023
CN
Method for detecting cytotoxicity of recombinant human coagulation factor VIII-Fc fusion protein
CN 117778517 A
申请人: CHENGDU RONGSHENG PHARMACEUTICALS CO LTD
优先权: 2023
CN
药物
反馈